Results 21 to 30 of about 19,967 (214)
Carbapenemase-producing Acinetobacter baumannii, Algeria [PDF]
European Journal of Clinical Microbiology & Infectious Diseases, 2010 EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, ISSN : 0934-9723, DOI : 10.1007/s10096-010-1011-2, Issue : 11, Volume : 29, pp. 1457-1458, November 2010.
DRISSI, M. +4 more
openaire +3 more sources
The Immaculate Carbapenemase Study [PDF]
Journal of Clinical Microbiology, 2017 ABSTRACT Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and are typically resistant to most (sometimes all) antibiotics. We now face a global CPO pandemic of high mortality. In this issue of the Journal of Clinical Microbiology , Karlowsky
openaire +2 more sources
Carbapenemase-Producing Organisms: A Global Scourge [PDF]
Clinical Infectious Diseases, 2017 The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic when encountered in members of the family Enterobacteriaceae.
Bonomo, Robert A +6 more
openaire +3 more sources
Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae [PDF]
Antimicrobial Stewardship & Healthcare Epidemiology, 2021 Background: Carbapenem-resistant Enterobacteriaceae (CRE) remain among the most urgent infectious threats according to the CDC Threats Reports. Although focus has often been placed on carbapenemase-producing phenotypes, there is increasing interest in distinguishing the optimal treatment and outcomes of carbapenemase-producing (CP) and non ...
Clark, Justin, Burgess, David
openaire +1 more source
Antibiotics, 2021 The gastrointestinal tract is an important reservoir of extended spectrum beta-lactamase (ESBL)/carbapenemase-producing Enterobacterales isolates. This study included patients from two Bulgarian hospitals.
Rumyana Markovska +6 more
doaj +1 more source
, 2019 Carbapenems are usually regarded as the last treatment option for serious infections caused by Gram-negative and Gram-positive microorganisms. Although they are stable to hydrolysis by most β- lactamases, their usage as the last resort antbiotics was seriously compromised by the appearance of carbapenem-hydrolyzing enzymes called carbapenemases.
Bedenić, Branka, Sardelić, Sanda
openaire +2 more sources
Medicina, 2023 Background and Objectives: In Peru, the presence of antimicrobial-resistant bacteria is a constant concern in hospitals and has likely increased in frequency during the pandemic.
David García-Cedrón +7 more
doaj +1 more source
Antibiotics, 2023 Hospital wastewater is a recognized reservoir for resistant Gram-negative bacteria. This study aimed to screen for carbapenemase-producing Escherichia coli and Klebsiella pneumoniae and their resistance determinants in two hospital effluents of ...
Alix Bénédicte Kagambèga +8 more
doaj +1 more source
First report of OXA-48-producing Klebsiella pneumoniae strains in Iran
GMS Hygiene and Infection Control, 2014 [english] Carbapenem-resistant are increasingly reported worldwide and cause therapeutic problem in health care facilities. In this study 28 imipenem-resistant were examined for expression of carbapenemases by phenotypic and genotypic methods. Modified
Azimi, Leila +3 more
doaj +1 more source
Klebsiella pneumoniaeCarbapenemase, Canada
Emerging Infectious Diseases, 2009 To the Editor: Carbapenems are used to treat life-threatening infections caused by extremely drug-resistant gram-negative pathogens; these drugs represent the last line of defense in the antimicrobial drug armamentarium against serious or invasive infection (1). The rapid global spread of Klebsiella pneumoniae that produces K. pneumoniae carbapenemase (
Dylan R. Pillai +8 more
openaire +2 more sources